Stock DNA
Pharmaceuticals & Biotechnology
CNY 15,370 Million (Large Cap)
27.00
NA
1.80%
-0.49
15.57%
3.77
Revenue and Profits:
Net Sales:
815 Million
(Quarterly Results - Sep 2025)
Net Profit:
150 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.88%
0%
-0.88%
6 Months
-6.4%
0%
-6.4%
1 Year
18.23%
0%
18.23%
2 Years
36.01%
0%
36.01%
3 Years
-12.65%
0%
-12.65%
4 Years
-26.7%
0%
-26.7%
5 Years
-38.32%
0%
-38.32%
Micro-Tech (Nanjing) Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
18.79%
EBIT Growth (5y)
19.52%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
0.69
Tax Ratio
14.35%
Dividend Payout Ratio
50.85%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
29.75%
ROE (avg)
12.38%
Valuation key factors
Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
4.13
EV to EBIT
24.17
EV to EBITDA
19.73
EV to Capital Employed
7.15
EV to Sales
4.97
PEG Ratio
1.72
Dividend Yield
1.67%
ROCE (Latest)
29.58%
ROE (Latest)
15.58%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
815.20
866.20
-5.89%
Operating Profit (PBDIT) excl Other Income
173.90
236.00
-26.31%
Interest
1.40
0.50
180.00%
Exceptional Items
0.10
0.40
-75.00%
Consolidate Net Profit
150.30
212.60
-29.30%
Operating Profit Margin (Excl OI)
213.30%
233.10%
-1.98%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is -5.89% vs 23.88% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is -29.30% vs 27.15% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
2,736.80
2,394.20
14.31%
Operating Profit (PBDIT) excl Other Income
702.50
531.40
32.20%
Interest
11.10
8.40
32.14%
Exceptional Items
-5.00
0.40
-1,350.00%
Consolidate Net Profit
568.10
494.70
14.84%
Operating Profit Margin (Excl OI)
214.90%
187.40%
2.75%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 14.31% vs 21.59% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 14.84% vs 48.65% in Dec 2023
About Micro-Tech (Nanjing) Co., Ltd. 
Micro-Tech (Nanjing) Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






